Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Key Details
Context & Analysis
National Institutes of Health posted this funding opportunity on June 3, 2026 (opportunity number RFA-CA-27-002). It is catalogued under CFDA number 93.394. Applications are accepted through November 10, 2026 — 157 days remaining.
Similar Grant Opportunities
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
National Institutes of Health
Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
National Institutes of Health
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
National Institutes of Health
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
National Institutes of Health
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
National Institutes of Health
Stay Updated
Get notified about new opportunities matching your interests.